Top

Diabetology & Metabolic Syndrome

Published in:

Open Access 01-12-2021 | COVID-19 | Review

Impact of COVID-19 lockdown on glycemic control in patients with type 1 and type 2 diabetes mellitus: a systematic review

Authors: Claudia Eberle, Stefanie Stichling

Published in: Diabetology & Metabolic Syndrome | Issue 1/2021

Abstract

Background

In 2019, a new virus known as severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) has emerged. Coronavirus disease 2019 (COVID-19) was classified as a pandemic in a short period of time. In order to reduce the spread of COVID-19, many countries have imposed a lockdown with movement restrictions, social distancing and home confinement, which has affected routine healthcare activities and everyday life. The aim of this systematic review was to examine the impact of the COVID-19 lockdown on glycemic control in patients with type 1 diabetes (T1D) and type 2 diabetes (T2D).

Methods

We systematically identified studies by searching the databases Cochrane Library, MEDLINE via PubMed, Web of Science Core Collection, EMBASE, and CINAHL until April 2021. We included n = 33 observational studies of which n = 25 investigated T1D and n = 8 T2D.

Results

Overall, we analyzed n = 2881 T1D patients and n = 1823 T2D patients. Glycemic values in patients with T1D improved significantly during lockdown. Overall, n = 18 (72%) T1D studies indicated significant improvements in glycemic outcomes. Meta-analysis revealed a mean difference in HbA1c of − 0.05% (95% CI − 0.31 to 0.21) due to lockdown, and in time in range (TIR) of + 3.75% (95% CI 2.56 to 4.92). Lockdown determined a short-term worsening in glycemic values in patients with T2D. Overall, n = 4 (50%) publications observed deteriorations in glycemic control. Meta-analysis demonstrated a mean difference in HbA1c of + 0.14 (95% CI − 0.13 to 0.40) through the lockdown. Moreover, n = 3 (75%) studies reported a not significant deterioration in body weight.

Conclusions

Glycemic values in people with T1D significantly improved during COVID-19 lockdown, which may be associated with positive changes in self-care and digital diabetes management. In contrast, lockdown rather determined a short-term worsening in glycemic parameters in patients with T2D. Further research is required, particularly into the causes and effective T2D management during lockdown.

Available only for authorised users

World Health Organization. WHO coronavirus (COVID-19) dashboard | WHO coronavirus disease (COVID-19) dashboard. https://covid19.who.int/. Accessed 5 Mar 2021.

Verity R, Okell LC, Dorigatti I, Winskill P, Whittaker C, Imai N, et al. Estimates of the severity of coronavirus disease 2019: a model-based analysis. Lancet Infect Dis. 2020;20:669–77. https://doi.org/10.1016/S1473-3099(20)30243-7.CrossRefPubMedPubMedCentral

Kleinwechter H, Laubner K. Coronavirus disease 2019 (COVID-19) and pregnancy: overview and report of the first German case with COVID-19 and gestational diabetes. Diabetologe. 2020;16:242–6. https://doi.org/10.1007/s11428-020-00611-0.CrossRef

Bajgain KT, Badal S, Bajgain BB, Santana MJ. Prevalence of comorbidities among individuals with COVID-19: a rapid review of current literature. Am J Infect Control. 2020. https://doi.org/10.1016/j.ajic.2020.06.213.CrossRefPubMedPubMedCentral

International Diabetes Federation. IDF diabetes atlas, 9th edition 2019. 2020. https://www.diabetesatlas.org/en/resources/.

American Diabetes Association. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2020. Diabetes Care. 2020;43:S14–31. https://doi.org/10.2337/dc20-S002.CrossRef

American Diabetes Association. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2019. Diabetes Care. 2019;42:S13–28. https://doi.org/10.2337/dc19-S002.CrossRef

Viigimaa M, Sachinidis A, Toumpourleka M, Koutsampasopoulos K, Alliksoo S, Titma T. Macrovascular complications of type 2 diabetes mellitus. Curr Vasc Pharmacol. 2020;18:110–6. https://doi.org/10.2174/1570161117666190405165151.CrossRefPubMed

Gupta R, Ghosh A, Singh AK, Misra A. Clinical considerations for patients with diabetes in times of COVID-19 epidemic. Diabetes Metab Syndr. 2020;14:211–2. https://doi.org/10.1016/j.dsx.2020.03.002.CrossRefPubMedPubMedCentral

10.

Kleinwechter H. Diabetes and pregnancy—update 2020. Diabetologe. 2020;16:470–7. https://doi.org/10.1007/s11428-020-00629-4.CrossRef

11.

Desvars-Larrive A, Dervic E, Haug N, Niederkrotenthaler T, Chen J, Di Natale A, et al. A structured open dataset of government interventions in response to COVID-19. Sci Data. 2020;7:285. https://doi.org/10.1038/s41597-020-00609-9.CrossRefPubMedPubMedCentral

12.

Scott ES, Jenkins AJ, Fulcher GR. Challenges of diabetes management during the COVID-19 pandemic. Med J Aust. 2020;213:56-57.e1. https://doi.org/10.5694/mja2.50665.CrossRefPubMed

13.

World Health Organization. Telemedicine: opportunities and developments in member states. Report on the Second Global Survey on eHealth 2009. Geneva: World Health Organization; 2010.

14.

Tornese G, Ceconi V, Monasta L, Carletti C, Faleschini E, Barbi E. Glycemic control in type 1 diabetes mellitus during COVID-19 quarantine and the role of in-home physical activity. Diabetes Technol Ther. 2020;22:462–7. https://doi.org/10.1089/dia.2020.0169.CrossRefPubMed

15.

Pla B, Arranz A, Knott C, Sampedro M, Jiménez S, Hernando I, Marazuela M. Impact of COVID-19 lockdown on glycemic control in adults with type 1 diabetes mellitus. J Endocr Soc. 2020;4:bvaa149. https://doi.org/10.1210/jendso/bvaa149.CrossRefPubMedPubMedCentral

16.

Moreno-Domínguez Ó, González-Pérez de Villar N, Barquiel B, Hillman-Gadea N, Gaspar-Lafuente R, Arévalo-Gómez M, Herranz L. Factors related to improvement of glycemic control among adults with type 1 diabetes during lockdown due to COVID-19. Diabetes Technol Ther. 2020. https://doi.org/10.1089/dia.2020.0550.CrossRefPubMed

17.

Di Dalmazi G, Maltoni G, Bongiorno C, Tucci L, Di Natale V, Moscatiello S, et al. Comparison of the effects of lockdown due to COVID-19 on glucose patterns among children, adolescents, and adults with type 1 diabetes: CGM study. BMJ Open Diabetes Res Care. 2020. https://doi.org/10.1136/bmjdrc-2020-001664.CrossRefPubMedPubMedCentral

18.

Tinti D, Savastio S, Grosso C, de Donno V, Trada M, Nugnes M, et al. Impact of lockdown during COVID-19 emergency on glucose metrics of children and adolescents with type 1 diabetes in Piediabetesont, Italy. Acta Diabetol. 2021. https://doi.org/10.1007/s00592-021-01702-0.CrossRefPubMedPubMedCentral

19.

Mesa A, Viñals C, Pueyo I, Roca D, Vidal M, Giménez M, Conget I. The impact of strict COVID-19 lockdown in Spain on glycemic profiles in patients with type 1 diabetes prone to hypoglycemia using standalone continuous glucose monitoring. Diabetes Res Clin Pract. 2020;167: 108354. https://doi.org/10.1016/j.diabres.2020.108354.CrossRefPubMedPubMedCentral

20.

Predieri B, Leo F, Candia F, Lucaccioni L, Madeo SF, Pugliese M, et al. Glycemic control improvement in Italian children and adolescents with type 1 diabetes followed through telemedicine during lockdown due to the COVID-19 pandemic. Front Endocrinol. 2020;11: 595735. https://doi.org/10.3389/fendo.2020.595735.CrossRef

21.

Capaldo B, Annuzzi G, Creanza A, Giglio C, de Angelis R, Lupoli R, et al. Blood glucose control during lockdown for COVID-19: CGM metrics in Italian adults with type 1 diabetes. Diabetes Care. 2020;43:e88–9. https://doi.org/10.2337/dc20-1127.CrossRefPubMedPubMedCentral

22.

Bonora BM, Boscari F, Avogaro A, Bruttomesso D, Fadini GP. Glycaemic control among people with type 1 diabetes during lockdown for the SARS-CoV-2 outbreak in Italy. Diabetes Ther. 2020. https://doi.org/10.1007/s13300-020-00829-7.CrossRefPubMedPubMedCentral

23.

Dover AR, Ritchie SA, McKnight JA, Strachan MWJ, Zammitt NN, Wake DJ, et al. Assessment of the effect of the COVID-19 lockdown on glycaemic control in people with type 1 diabetes using flash glucose monitoring. Diabet Med. 2021;38: e14374. https://doi.org/10.1111/diabetese.14374.CrossRefPubMed

24.

Caruso I, Di Molfetta S, Guarini F, Giordano F, Cignarelli A, Natalicchio A, et al. Reduction of hypoglycaemia, lifestyle modifications and psychological distress during lockdown following SARS-CoV-2 outbreak in type 1 diabetes. Diabetes Metab Res Rev. 2020. https://doi.org/10.1002/diabetesrr.3404.CrossRefPubMedPubMedCentral

25.

Fernández E, Cortazar A, Bellido V. Impact of COVID-19 lockdown on glycemic control in patients with type 1 diabetes. Diabetes Res Clin Pract. 2020;166: 108348. https://doi.org/10.1016/j.diabres.2020.108348.CrossRefPubMedPubMedCentral

26.

Longo M, Caruso P, Petrizzo M, Castaldo F, Sarnataro A, Gicchino M, et al. Glycemic control in people with type 1 diabetes using a hybrid closed loop system and followed by telemedicine during the COVID-19 pandemic in Italy. Diabetes Res Clin Pract. 2020;169: 108440. https://doi.org/10.1016/j.diabres.2020.108440.CrossRefPubMedPubMedCentral

27.

Viñals C, Mesa A, Roca D, Vidal M, Pueyo I, Conget I, Giménez M. Management of glucose profile throughout strict COVID-19 lockdown by patients with type 1 diabetes prone to hypoglycaemia using sensor-augmented pump. Acta Diabetol. 2021;58:383–8. https://doi.org/10.1007/s00592-020-01625-2.CrossRefPubMed

28.

Cognigni M, D’Agostin M, Schiulaz I, Giangreco M, Carletti C, Faleschini E, et al. HbA1c and BMI after lockdown for COVID-19 in children and adolescents with type 1 diabetes mellitus. Acta Paediatr. 2021. https://doi.org/10.1111/apa.15838.CrossRefPubMedPubMedCentral

29.

Aragona M, Rodia C, Bertolotto A, Campi F, Coppelli A, Giannarelli R, et al. Type 1 diabetes and COVID-19: the “lockdown effect.” Diabetes Res Clin Pract. 2020;170: 108468. https://doi.org/10.1016/j.diabres.2020.108468.CrossRefPubMedPubMedCentral

30.

Marigliano M, Maffeis C. Glycemic control of children and adolescents with type 1 diabetes improved after COVID-19 lockdown in Italy. Acta Diabetol. 2021. https://doi.org/10.1007/s00592-020-01667-6.CrossRefPubMedPubMedCentral

31.

Prabhu Navis J, Leelarathna L, Mubita W, Urwin A, Rutter MK, Schofield J, Thabit H. Impact of COVID-19 lockdown on flash and real-time glucose sensor users with type 1 diabetes in England. Acta Diabetol. 2021;58:231–7. https://doi.org/10.1007/s00592-020-01614-5.CrossRefPubMed

32.

Cotovad-Bellas L, Tejera-Pérez C, Prieto-Tenreiro A, Sánchez-Bao A, Bellido-Guerrero D. The challenge of diabetes home control in COVID-19 times: proof is in the pudding. Diabetes Res Clin Pract. 2020;168: 108379. https://doi.org/10.1016/j.diabres.2020.108379.CrossRefPubMedPubMedCentral

33.

Christoforidis A, Kavoura E, Nemtsa A, Pappa K, Dimitriadou M. Coronavirus lockdown effect on type 1 diabetes management οn children wearing insulin pump equipped with continuous glucose monitoring system. Diabetes Res Clin Pract. 2020;166: 108307. https://doi.org/10.1016/j.diabres.2020.108307.CrossRefPubMedPubMedCentral

34.

Wu X, Luo S, Zheng X, Ding Y, Wang S, Ling P, et al. Glycemic control in children and teenagers with type 1 diabetes around lockdown for COVID-19: a continuous glucose monitoring-based observational study. J Diabetes Investig. 2021. https://doi.org/10.1111/jdi.13519.CrossRefPubMedPubMedCentral

35.

Brener A, Mazor-Aronovitch K, Rachmiel M, Levek N, Barash G, Pinhas-Hamiel O, et al. Lessons learned from the continuous glucose monitoring metrics in pediatric patients with type 1 diabetes under COVID-19 lockdown. Acta Diabetol. 2020;57:1511–7. https://doi.org/10.1007/s00592-020-01596-4.CrossRefPubMed

36.

Hosomi Y, Munekawa C, Hashimoto Y, Okamura T, Takahashi F, Kawano R, et al. Effect of COVID-19 pandemic on the lifestyle and glycemic control in patients with type 1 diabetes: a retrospective cohort study. Diabetol Int. 2020. https://doi.org/10.1007/s13340-021-00507-4.CrossRef

37.

Al Agha AE, Alharbi RS, Almohammadi OA, Yousef SY, Sulimani AE, Alaama RA. Impact of COVID-19 lockdown on glycemic control in children and adolescents. Saudi Med J. 2021;42:44–8. https://doi.org/10.15537/smj.2021.1.25620.CrossRefPubMed

38.

Verma A, Rajput R, Verma S, Balania VKB, Jangra B. Impact of lockdown in COVID 19 on glycemic control in patients with type 1 diabetes mellitus. Diabetes Metab Syndr. 2020;14:1213–6. https://doi.org/10.1016/j.dsx.2020.07.016.CrossRefPubMedPubMedCentral

39.

Önmez A, Gamsızkan Z, Özdemir Ş, Kesikbaş E, Gökosmanoğlu F, Torun S, Cinemre H. The effect of COVID-19 lockdown on glycemic control in patients with type 2 diabetes mellitus in Turkey. Diabetes Metab Syndr. 2020;14:1963–6. https://doi.org/10.1016/j.dsx.2020.10.007.CrossRefPubMedPubMedCentral

40.

Karatas S, Yesim T, Beysel S. Impact of lockdown COVID-19 on metabolic control in type 2 diabetes mellitus and healthy people. Prim Care Diabetes. 2021. https://doi.org/10.1016/j.pcd.2021.01.003.CrossRefPubMedPubMedCentral

41.

Biancalana E, Parolini F, Mengozzi A, Solini A. Short-term impact of COVID-19 lockdown on metabolic control of patients with well-controlled type 2 diabetes: a single-centre observational study. Acta Diabetol. 2020. https://doi.org/10.1007/s00592-020-01637-y.CrossRefPubMedPubMedCentral

42.

Khare J, Jindal S. Observational study on effect of lock down due to COVID 19 on glycemic control in patients with diabetes: experience from Central India. Diabetes Metab Syndr. 2020;14:1571–4. https://doi.org/10.1016/j.dsx.2020.08.012.CrossRefPubMedPubMedCentral

43.

Falcetta P, Aragona M, Ciccarone A, Bertolotto A, Campi F, Coppelli A, et al. Impact of COVID-19 lockdown on glucose control of elderly people with type 2 diabetes in Italy. Diabetes Res Clin Pract. 2021. https://doi.org/10.1016/j.diabres.2021.108750.CrossRefPubMed

44.

Sankar P, Ahmed WN, Mariam Koshy V, Jacob R, Sasidharan S. Effects of COVID-19 lockdown on type 2 diabetes, lifestyle and psychosocial health: a hospital-based cross-sectional survey from South India. Diabetes Metab Syndr. 2020;14:1815–9. https://doi.org/10.1016/j.dsx.2020.09.005.CrossRefPubMedPubMedCentral

45.

Psoma O, Papachristoforou E, Kountouri A, Balampanis K, Stergiou A, Lambadiari V, et al. Effect of COVID-19-associated lockdown on the metabolic control of patients with type 2 diabetes. J Diabetes Complicat. 2020;34: 107756. https://doi.org/10.1016/j.jdiacomp.2020.107756.CrossRef

46.

Rastogi A, Hiteshi P, Bhansali A. Improved glycemic control amongst people with long-standing diabetes during COVID-19 lockdown: a prospective, observational, nested cohort study. Int J Diabetes Dev Ctries. 2020. https://doi.org/10.1007/s13410-020-00880-x.CrossRefPubMed

47.

Tan SY, Mei Wong JL, Sim YJ, Wong SS, Mohamed Elhassan SA, Tan SH, et al. Type 1 and 2 diabetes mellitus: a review on current treatment approach and gene therapy as potential intervention. Diabetes Metab Syndr. 2019;13:364–72. https://doi.org/10.1016/j.dsx.2018.10.008.CrossRefPubMed

48.

Eberle C, Stichling S, Löhnert M. Diabetology 4.0: scoping review of novel insights and possibilities offered by digitalization. J Med Internet Res. 2020;23(3):e23475.CrossRef

49.

Eberle C, Stichling S. Clinical improvements by telemedicine interventions managing type 1 and type 2 diabetes: systematic meta-review. J Med Internet Res. 2020;23(2):e23244.CrossRef

50.

Lippi G, Henry BM, Bovo C, Sanchis-Gomar F. Health risks and potential remedies during prolonged lockdowns for coronavirus disease 2019 (COVID-19). Diagnosis. 2020;7:85–90. https://doi.org/10.1515/dx-2020-0041.CrossRefPubMed

51.

Ghosh A, Arora B, Gupta R, Anoop S, Misra A. Effects of nationwide lockdown during COVID-19 epidemic on lifestyle and other medical issues of patients with type 2 diabetes in north India. Diabetes Metab Syndr. 2020;14:917–20. https://doi.org/10.1016/j.dsx.2020.05.044.CrossRefPubMedPubMedCentral

52.

Ruiz-Roso MB, Knott-Torcal C, Matilla-Escalante DC, Garcimartín A, Sampedro-Nuñez MA, Dávalos A, Marazuela M. COVID-19 lockdown and changes of the dietary pattern and physical activity habits in a cohort of patients with type 2 diabetes mellitus. Nutrients. 2020. https://doi.org/10.3390/nu12082327.CrossRefPubMedPubMedCentral

53.

Fonseca VA, Smith H, Kuhadiya N, Leger SM, Yau CL, Reynolds K, et al. Impact of a natural disaster on diabetes: exacerbation of disparities and long-term consequences. Diabetes Care. 2009;32:1632–8. https://doi.org/10.2337/dc09-0670.CrossRefPubMedPubMedCentral

54.

Rubinstein A, Koffler M, Villa Y, Graff E. The Gulf War and diabetes mellitus. Diabet Med. 1993;10:774–6. https://doi.org/10.1111/j.1464-5491.1993.tb00163.x.CrossRefPubMed

55.

Ghesquière L, Garabedian C, Drumez E, Lemaître M, Cazaubiel M, Bengler C, Vambergue A. Effects of COVID-19 pandemic lockdown on gestational diabetes mellitus: a retrospective study. Diabetes Metab. 2021;47: 101201. https://doi.org/10.1016/j.diabet.2020.09.008.CrossRefPubMed

Title: Impact of COVID-19 lockdown on glycemic control in patients with type 1 and type 2 diabetes mellitus: a systematic review
Authors: Claudia Eberle
Stefanie Stichling
Publication date: 01-12-2021
Publisher: BioMed Central
Keywords: COVID-19
Type 1 Diabetes
Type 2 Diabetes
Published in: Diabetology & Metabolic Syndrome / Issue 1/2021
Electronic ISSN: 1758-5996
DOI: https://doi.org/10.1186/s13098-021-00705-9

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

Illustration of figure on mountain summit/© Orapun / Stock.adobe.com, STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2021

Time in range, especially overnight time in range, is associated with sudomotor dysfunction in patients with type 1 diabetes

Outcome and death risk of diabetes patients with Covid-19 receiving pre-hospital and in-hospital metformin therapies

Ethnic disparity in metabolic syndrome and related obesity and health behavior: a community study in Taiwan

Anthropometric indices and the risk of incident sudden cardiac death among adults with and without diabetes: over 15 years of follow-up in The Tehran Lipid and Glucose Study

The best drug supplement for obesity treatment: a systematic review and network meta-analysis

Clinical characteristics, gestational weight gain and pregnancy outcomes in women with a history of gestational diabetes mellitus

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage